Skip to main content

Francisella tularensis human infections in a village of northwest Iran

Abstract

Background

Recent seroepidemiological studies have suggested that tularemia could be an endemic bacterial zoonosis in Iran.

Methods

From January 2016 to June 2018, disease cases characterized by fever, cervical lymphadenopathy and ocular involvement were reported in Youzband Village of Kaleybar County, in the East Azerbaijan Province, northwestern Iran. Diagnostic tests included Francisella tularensis serology (including tube agglutination test and ELISA), PCR, and culture.

Results

Among 11 examined case-patients, the tularemia tube agglutination test was positive in ten and borderline in one. PCR detected the F. tularensis ISFtu2 elements and fopA gene in one rodent and a spring water sample from the same geographic area.

Conclusions

Based on the clinical manifestations of the disease suggesting an oropharyngeal form of tularemia, serology results in case patients, and F. tularensis detection in the local fauna and aquatic environment, the water supply of the village was the likely source of the tularemia outbreak. Intervention such as dredging and chlorination of the main water storage tank of the village and training of villagers and health care workers in preventive measures and treatment of the illness helped control the infection.

Peer Review reports

Introduction

Tularemia is a zoonotic disease caused by the Gram-negative bacterium Francisella tularensis [1]. The disease classically manifests by six clinical forms, the ulceroglandular, glandular, oculoglandular, oropharyngeal, respiratory, and typhoidal forms. The ulceroglandular and glandular forms correspond to chronic lymphadenopathy, with or without a skin inoculation lesion, respectively. The oropharyngeal form corresponds to pharyngitis with cervical lymphadenopathy. It is mainly caused by the consumption of contaminated water or food. The oculoglandular form is a conjunctivitis with regional lymphadenopathy, usually transmitted through the touch of eyes with contaminated fingers or by an ocular projection of contaminated water or dust. The respiratory and typhoidal forms are usually more severe systemic diseases [1, 2].

F. tularensis has three subspecies, namely tularensis (type A), holarctica (type B), and mediasiatica that are different in terms of reservoirs, life cycle, and geographic distribution. Only type A and type B strains are known causative agents of tularemia in human. Type A strains are reported in North America, and type B is common in Europe and Asia [1]. Two aquatic and terrestrial cycles have been described for both subspecies [3,4,5]. In the terrestrial cycle, rabbits and hares are hosts and reservoirs of the disease, and ticks play a major role as vectors in the animal reservoir. In the aquatic cycle, which is more common for type B strains, small rodents contaminate the aquatic environment with F. tularensis, and tularemia can be transmitted to humans by drinking contaminated water, and in some areas (Sweden, Finland and Russia) through mosquito bites. However, type B strains can also be found in hares, rodents and other animals [3]. In regions with type B tularemia, drinking water from ponds, lakes and rivers and eating contaminated vegetables can transmit the disease [4, 6].

Tularemia is classically restricted to the Northern hemisphere, although it has been recently reported in Australia [7]. It is more common in the USA and Northern Europe (Scandinavia) [1], and disease foci are found in Russia, Kazakhstan, and Turkmenistan [8, 9]. Tularemia has been reported in animals or humans in several countries with common borders with northern Iran, such as Turkmenistan, Kazakhstan, Azerbaijan and Armenia [10]. This disease is highly endemic in Turkey [11], where 1300 human infections have been reported in different regions during the 1988 to 2009 period [6, 12].

The first serosurvey of tularemia in wild mammals and livestock from different regions of Iran, in 1972, showed evidence of F. tularensis circulation among sheep and cows in the northwestern part of Iran, but also in a hedgehog in the southeastern part [13]. In 1980, the first human case of tularemia (a glandular form) was reported in Kurdistan province, in western Iran [14]. Since 2011, with the establishment of the national tularemia laboratory in the Pasteur Institute of Iran, extensive studies have been done in this field in Iran. According to conducted serosurveys on Kurdistan province residents during 2011–2012, 14.4% of studied participants had anti-F. tularensis antibodies [15]. In 2011, the seroprevalence of tularemia was found to be 6.52% among butchers and slaughterhouse workers of Sistan and Baluchestan province, southeastern Iran [16]. In 2013, a seropositive rodent was found in the northern Sistan and Baluchistan [17]. During another research in Kurdistan province in 2014, seropositive tularemia samples were reported among rodents [18]. In 2014 and 2015, rodents trapped in the Golestan (northern Iran), Khuzestan (southwestern Iran) and Razavi Khorasan (northeastern Iran) provinces, and hares from Khuzestan, and Sistan and Baluchestan provinces (southeastern Iran) were PCR-positive for F. tularensis [19]. In 2017, a human case of hare-borne tularemia was diagnosed in Kurdistan province [20].

According to previous studies and current epidemiological data in neighboring countries such as Turkey, an aquatic cycle could be suspected in Iran.

Materials and methods

Outbreak site

Youzband is a village of East Azerbaijan Province in the northwest of Iran, located 18 km from Kaleybar County. The village’s population was 719 in 2017. The village is situated at 1600 m elevation above sea level.

Reported cases

From December 2016, a disease was observed in the village affecting humans from different families and of different ages. Clinical manifestations included fever, fatigue, muscle aches, and the development of swollen lymph nodes, mainly in the neck. Thirteen patients had been suffering from this disease, according to the recorded data at the village health House (Fig. 1).

Fig. 1
figure1

Cervical adenopathy in some tularemia patients

Patients were referred to the provincial and hospital centers in Kaleybar County for diagnosis, and most of them received antibiotics such as amoxicillin, coamoxiclav, penicillin, ceftazidime, and cefixime. In some cases, surgical lymph node removal was performed. Two patients received anti-tuberculosis treatment despite a negative acid fast-staining of histological preparation of removed tissue samples. Some patients did not receive any treatment as the swollen lymph nodes drained into or out of the body. With regard to clinical manifestations, four pathogens were suspected in the differential diagnosis by physicians, including Francisella tularensis, Yersinia pseudotuberculosis, Yersinia pestis and Bartonella henselae.

Environmental observations and epidemiological evidence

A water-borne disease was strongly suspected during the investigation carried out in the village by the epidemic control team of the Pasteur Institute of Iran. No similar disease was found in surrounding villages. The investigation team found out that the villagers of Youzband village preferably used drinking water from local springs because they disliked the water of the local water supply system having an unpleasant taste and color. Data from registry offices indicated that the chlorination of the village tap water was insufficient 1 year before the disease emergence. In interviews with villagers, an unusual abundance of rodents in the summer of 2016 was frequently mentioned.

Given epidemiological, environmental and clinical findings, the suspicion of a tularemia outbreak became more serious, and it was decided to perform clinical diagnostic sampling of humans and send serum, blood and lymph nodes specimens to the Pasteur Institute of Iran.

Specimens for microbiological testing

Among humans with a clinical history of suspected tularemia manifestations during the previous 18 months, eleven were still ill and expressed their consent to provide blood samples at the time of the outbreak investigation in June 2018. We collected serum samples from all patients, whole blood samples from six patients, and five samples from village’s water resources, including spring water and tap water. In addition, nine rodents were captured from around the water resources, and rodent serum and spleen tissue samples were collected.

Demographic and clinical data of patients

A researcher-made survey questionnaire was used to collect information from the patients. The patients’ mean age was 30 years (the youngest was 4, and the oldest was 77). The swollen lymph nodes were retropharyngeal in six patients, parotid in three, and at both locations in two patients. One patient had swollen inguinal lymph nodes. In two patients, there was no swelling of lymph nodes but swelling and redness of the eyes. Physical examination of the patients revealed redness of the oropharyngeal mucosa. The disease was accompanied by cervical and preauricular swollen lymph nodes, usually unilateral. In four patients, lymph node swelling had disappeared, resulting in spontaneous skin drainage with pus suppuration.

Seven patients reported the onset of symptoms in 2016 (including two in December) and two patients in 2017 (in March and October, respectively). Two patients with severe illness required hospitalization. Two patients consumed only spring water, three only tap water, and six drank both spring and tap water. Two patients pointed out that another member of their families had also been affected by the same clinical manifestations (Table 1).

Table 1 Demographic, epidemiological and clinical data and test results for 11 patients involved in tularemia outbreak in Youzband Village, 2016–2018

Rodent sampling

Rodent sampling was carried out around the affected village and its springs. Trapping was conducted using traditional live-catch traps with baits (dates, cucumber and cheese puffs). Rodents were identified using morphological traits as identification keys [21, 22]. Serum and spleen samples from rodents were transferred at 4 °C to the national Reference Laboratory for Plague, Tularemia and Q fever, at the Pasteur Institute of Iran laboratory.

Culturing of rodent samples

Samples of rodents’ spleen were homogenized with sterile saline. To investigate the presence of F. tularensis, 50 μl of homogenized spleen samples were inoculated to sheep blood agar and Cysteine Heart Agar with 9% chocolatized sheep blood (CHAB) made selective by adding Cycloheximide, Vancomycin, Trimethoprim, Sulfamethoxazole and Colistin [23]. Agar plates were incubated in 5% CO2-enriched atmosphere at 37 °C for a week. Bacterial growth was monitored daily.

Culturing water samples

From each water source, six samples (2.5 l per sample) were collected. Water samples were transferred to the laboratory at 4–8 °C within 48 h. Each sample was filtered on two 0.22-μm filters using a vacuum pump concentration system (Millipore, Burlington, Massachusetts, United States). The first filter was used for culture and divided into two parts. One part was directly inoculated to CHAB medium with antibiotics. The second part was first inoculated to the enrichment broth medium T [24] for 48 h, and then cultured on CHAB medium. The second filter of each sample was used for direct DNA extraction from the re-suspended filtrate in sterile PBS buffer. After 72 h incubation of the plates, DNA extraction was performed for all bacteria cultivated. All the extracted DNAs from different samples were tested by Real-Time PCR assays.

Genome extraction and real-time PCR testing

DNA was extracted from each rodent spleen sample using the High Pure PCR template preparation kit (Roche). Real-time PCR testing for detection of Francisella spp. targeted the ISFtu2 elements (Table 2) [25], using the Rotor-Gene device (model 6000, Corbett Life Science) and previously described protocols [19]. ISFtu2 positive samples were tested using fopA real-time PCR to confirm F. tularensis infection (Table 2) [26]. The NCTC 10857 Strain of F. tularensis was used as a positive control.

Table 2 Primers and probes used for detection of F. tularensis

Standard tube agglutination procedure for detection of antibodies against F. tularensis

Standard tube agglutination was performed on all human and rodent serum samples according to the protocol of the manufacturer (Bioveta Inc., ivanovice, Czech Republic) to detect antibodies against F. tularensis. Antibody titers ≥80 were considered positive, and a titer at 40 was considered suspicious [27].

ELISA

Furthermore, the presence of Anti-F. tularensis IgG and IgM antibodies in patients’ serum samples were tested using ELISA quantitative kits (Serion/ Virion, Germany). Anti-F. tularensis IgG and IgM antibodies titers were determined using a standard curve (as recommended by the manufacturer), and amounts of IgM and IgG were reported as U/ml. According to the kit’s protocol, values less than 10 U/ml were considered negative, titers between 10 and 15 U/ml borderline, and those higher than 15 U/ml positive.

Results

All 11 examined patients’ sera had anti-F. tularensis antibodies of the IgM type, with very high titers (above 195 U/ml) in nine patients. Ten patients also had high IgG titers, whereas IgG was not detected in one patient (case No. 11). The tularemia tube agglutination test was positive in ten patients, and an ambiguous titer (1:40) was found for a patient (Table 1).

Real-time PCR tests revealed that one out of 5 water samples belonging to one of the springs of the village was positive for ISFtu2 elements and fopA gene.

One Microtus socialis out of nine captured rodents from around the main well of the village was positive for ISFtu2 elements and fopA gene. The negative rodent samples belonged to Microtus socialis (2), Microtus mystacinus (1), Dryomys nitedula (1), Apodemus witherbyi (2), Arvicola persicus (1) and Meriones persicus (1).

No positive result was obtained by culture or serological testing for any of the rodent samples. Direct culture attempts using filtered water that was injected into laboratory animals did not yield F. tularensis. It was not possible to isolate F. tularensis from human lymph node and blood samples, nor from rodent spleen and water samples.

After confirmation of the tularemia outbreak, patients were treated with doxycycline, 200 mg daily in two oral doses, for at least 15 days. Dredging and chlorination of the main water storage tank of the village were done. Villagers were encouraged to use tap water and received training to boil the spring water before drinking. Training programs for villagers about tularemia and its transmission modes were provided by distributing educational brochures, holding face-to-face training courses and sharing related educational materials in the virtual spaces in which the villagers were active. Training courses about clinical symptoms and treatment of tularemia were given to physicians and health care workers within 1 month after outbreak confirmation. Two years after the outbreak verification and the interventions, all the patients were cured, and no new cases of the disease were reported.

Discussion

Here we present the first report of a probably tularemia outbreak in Iran. The extent of the outbreak and its probable source were determined by combining human, animal and environmental data.

More than 200 species of small mammals are known reservoirs of F. tularensis [1]. In a previous study performed in 2013 in Kurdistan province (western Iran), the seropositive rodents belonged to Microtus, Dryomys and Meriones [18]. In the present study, one rodent (Microtus socialis), out of nine collected and tested, was PCR-positive for F. tularensis. It is likely that rodents, like in many tularemia endemic areas, have an important role in the maintenance and transmission of this disease in Iran. Population growth in rodents is often associated with the occurrence of epizootics of tularemia, with massive contamination of the aquatic environment with F. tularensis [28]. The remarkably high density of rodents reported in the agricultural lands of the village in the summer of 2016 could have triggered the tularemia outbreak in this area.

We could not detect F. tularensis in all collected water samples, except for one of the spring water sources, but it has previously been reported that the time, type and location of water sampling play a major role in the ability to detect this pathogen during a tularemia outbreak [4].

In this outbreak, nine out of 11 evaluated patients had a disease compatible with typical oropharyngeal tularemia. This form of the disease is usually transmitted through drinking contaminated water of eating food washed with contaminated water. Tularemia is an endemic disease in Turkey that is the northwestern neighbor of Iran and located near this outbreak region [29,30,31]. From 1988 to 2009, 1300 cases of tularemia were reported in different regions of Turkey [6], almost all cases corresponding to the oropharyngeal form of the disease [6, 12]. Two patients involved in this outbreak suffered from swelling and redness of eyes, but without local lymphadenopathy as usually reported in the oculoglandular form of tularemia. This clinical form is transmitted through splashing or washing eyes with F. tularensis-contaminated water, or touching eyes with contaminated fingers. It is usually rare, accounting for less than 1% of human tularemia cases. Ocular forms of tularemia have been reported in Turkish patients [6]. Occasionally, both the oropharyngeal ad oculoglandular forms of tularemia may be combined. Interestingly, nine out of 11 patients diagnosed with tularemia had been suffering from this disease for more than 1.5 years and underwent various therapeutic and surgical treatments. However, due to the lack of diagnosis and proper treatment, they were not completely cured. Delay in diagnosis and treatment of tularemia cases in regions where tularemia is rarely reported is common, as the clinical signs of this disease are similar to those of a wide range of other infectious diseases [1].

In the present study, we used serological methods to diagnose tularemia cases. Serological tests represent the most commonly used method for tularemia diagnosis [32]. Specific antibodies against F. tularensis are usually detectable 10 to 20 days following disease onset [1, 32]. In a compatible clinical and epidemiological context, a single serum sample with a high antibody titer against F. tularensis antigen is considered diagnostic for tularemia. We could not isolate F. tularensis from human, rodent or aquatic samples. The sampling of patients was performed very late during the course of their disease, when bacteria had already been eliminated from the body by the immune system. In addition, most patients had already received several courses of antibiotic therapy. In patients with tularemia, the isolation of F. tularensis is usually successful only in the acute stage of infection, before a significant immune response has been mounted and appropriate antibiotic therapy has been administered. Culture of water and rodent samples and injection of these samples to laboratory animals did not allow isolation of F. tularensis. Previous studies also reported that the isolation rates of F. tularensis from environmental samples are very low [33]. Despite the fact that F. tularensis were not isolated in this outbreak investigation, the epidemiological and clinical evidence indicates that the outbreak was likely caused by F. tularensis subsp. holarctica. Until now, only this subspecies has caused tularemia in Europe and Asia. Human infections with type B strains commonly occurred from contaminated aquatic sources, including springs, wetlands, ponds, and rivers, and also from aquatic and semi-aquatic rodents [4].

Likely sources of human infections during this outbreak were the communal village tap water system and spring waters from the local environment. There are several pieces of evidence supporting this hypothesis: 1) the oropharyngeal form of tularemia was predominant, 2) all involved patients had drunk from the same tap or spring water (two drank only tap water, five cases only spring water, and four cases both tap and spring water), 3) there was a lack of proper chlorination of tap water during a long period before the outbreak, 4) an infected rodent was collected from the proximity of the main well resource of the village, and 5) improving prevention measures, including proper chlorination of the tap water supply allowed control of the tularemia epidemic.

In conclusion, lack of awareness of tularemia clinical manifestations in the general population and in health care workers, as well as the usual mild severity of type B tularemia cases likely explain that this disease is poorly diagnosed in Iran. In addition, specific tularemia diagnostic tests have been lacking for years in this country and have become available again only recently.

Conclusion

The investigations of this outbreak and other recent serosurvey studies confirm that tularemia is an endemic disease in Iran. It is suggested that training programs be made available to physicians and healthcare personnel in all the country to raise awareness about the sources and transmission routes of F. tularensis and clinical signs of tularemia. Further studies are also needed to better evaluate the role of water contamination, animal reservoirs and potential vectors of tularemia in Iran. Investigating the levels of F. tularensis contamination of surface waters and infection rates in humans, livestock and wildlife animals in different regions would better clarify the endemic situation of tularemia in Iran.

Availability of data and materials

The datasets used during the current study are available from the corresponding author on reasonable request.

Abbreviations

PCR:

Polymerase chain reaction

ELISA:

Enzyme-linked Immunosorbent Assay

F. tularensis :

Francisella tularensis

References

  1. 1.

    Sjöstedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci. 2007;1105(1):1–29. https://doi.org/10.1196/annals.1409.009.

    Article  PubMed  Google Scholar 

  2. 2.

    Maurin M, Pelloux I, Brion JP, Del Banõ J-N, Picard A. Human tularemia in France, 2006–2010. Clin Infect Dis. 2011;53(10):e133–41. https://doi.org/10.1093/cid/cir612.

    Article  PubMed  Google Scholar 

  3. 3.

    Jellison WL. Tularemia in North America, 1930–1974; 1974.

    Google Scholar 

  4. 4.

    Hennebique A, Boisset S, Maurin M. Tularemia as a waterborne disease: a review. Emerg Microbes Infect. 2019;8(1):1027–42. https://doi.org/10.1080/22221751.2019.1638734.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Maurin M, Gyuranecz M. Tularaemia: clinical aspects in Europe. Lancet Infect Dis. 2016;16(1):113–24. https://doi.org/10.1016/S1473-3099(15)00355-2.

    Article  PubMed  Google Scholar 

  6. 6.

    Akalin H, Helvaci S, Gedikoglu S. Re-emergence of tularemia in Turkey. Int J Infect Dis. 2009;13(5):547–51. https://doi.org/10.1016/j.ijid.2008.09.020.

    Article  PubMed  Google Scholar 

  7. 7.

    Eden J-S, Rose K, Ng J, Shi M, Wang Q, Sintchenko V, et al. Francisella tularensis ssp. holarctica in ringtail possums, Australia. Emerg Infect Dis. 2017;23(7):1198.

    CAS  Article  Google Scholar 

  8. 8.

    Petersen JM, Schriefer ME. Tularemia: emergence/re-emergence. Vet Res. 2005;36(3):455–67. https://doi.org/10.1051/vetres:2005006.

    Article  PubMed  Google Scholar 

  9. 9.

    Tärnvik A, Priebe H-S, Grunow R. Tularaemia in Europe: an epidemiological overview. Scand J Infect Dis. 2004;36(5):350–5. https://doi.org/10.1080/00365540410020442.

    Article  PubMed  Google Scholar 

  10. 10.

    Zargar A, Maurin M, Mostafavi E. Tularemia, a re-emerging infectious disease in Iran and neighboring countrie. Epidemiol Health. 2015;37. https://doi.org/10.4178/epih/e2015011.

  11. 11.

    Gurcan S, Karabay O, Karadenizli A, Karagol C, Kantardjiev T, Ivanov IN. Characteristics of the Turkish isolates of Francisella tularensis. Jpn J Infect Dis. 2008;61(3):223–5.

    CAS  PubMed  Google Scholar 

  12. 12.

    Gürcan Ş. Epidemiology of tularemia. Balkan Med J. 2014;31(1):3–10. https://doi.org/10.5152/balkanmedj.2014.13117.

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Arata A, Chamsa M, Farhang-Azad A, Meščerjakova I, Neronov V, Saidi S. First detection of tularaemia in domestic and wild mammals in Iran. Bull World Health Organ. 1973;49(6):597–603.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Karimi Y, Salarkia F, Ghasemi M. Tularemia: first human case in Iran. J Med Coun Iran. 1981;8:134–41.

    Google Scholar 

  15. 15.

    Esmaeili S, Gooya MM, Shirzadi MR, Esfandiari B, Amiri FB, Behzadi MY, et al. Seroepidemiological survey of tularemia among different groups in western Iran. Int J Infect Dis. 2014;18:27–31. https://doi.org/10.1016/j.ijid.2013.08.013.

    Article  PubMed  Google Scholar 

  16. 16.

    Esmaeili S, Esfandiari B, Maurin M, Gouya MM, Shirzadi MR, Amiri FB, et al. Serological survey of tularemia among butchers and slaughterhouse workers in Iran. Trans R Soc Trop Med Hyg. 2014;108(8):516–8. https://doi.org/10.1093/trstmh/tru094.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Pourhossein B, Esmaeili S, Gyuranecz M, Mostafavi E. Tularemia and plague survey in rodents in an earthquake zone in southeastern Iran. Epidemiol Health. 2015;37. https://doi.org/10.4178/epih/e2015050.

  18. 18.

    Mostafavi E, Shahraki AH, Japoni-Nejad A, Esmaeili S, Darvish J, Sedaghat MM, et al. A field study of plague and tularemia in rodents, Western Iran. Vector Borne Zoonotic Dis. 2017;17(4):247–53. https://doi.org/10.1089/vbz.2016.2053.

    Article  PubMed  Google Scholar 

  19. 19.

    Mostafavi E, Ghasemi A, Rohani M, Molaeipoor L, Esmaeili S, Mohammadi Z, et al. Molecular survey of tularemia and plague in small mammals from Iran. Front Cell Infect Microbiol. 2018;8:215. https://doi.org/10.3389/fcimb.2018.00215.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Rohani M, Mohsenpour B, Ghasemi A, Esmaeili S, Karimi M, Neubauer H, et al. A case report of human tularemia from Iran. Iran J Microbiol. 2018;10(4):250–3.

    PubMed  PubMed Central  Google Scholar 

  21. 21.

    Kryštufek B, Vohralík V, Janžekovič F. Mammals of Turkey and Cyprus: Rodentia I: Sciuridae, Dipodidae, Gliridae, Arvicolinae: Zgodovinsko društvo za južno Primorsko; 2005.

    Google Scholar 

  22. 22.

    Darvish J, Mohammadi Z, Mahmoudi A, Siahsarvie R. Faunistic and taxonomic study of rodents from northwestern Iran. Iran J Anim Biosystematics. 2014;10(2):119–36.

    Google Scholar 

  23. 23.

    Petersen J, Carlson J, Yockey B, Pillai S, Kuske C, Garbalena G, et al. Direct isolation of Francisella spp. from environmental samples. Lett Appl Microbiol. 2009;48(6):663–7. https://doi.org/10.1111/j.1472-765X.2009.02589.x.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Becker S, Lochau P, Jacob D, Heuner K, Grunow R. Successful re-evaluation of broth medium T for growth of Francisella tularensis ssp. and other highly pathogenic bacteria. J Microbiol Methods. 2016;121:5–7. https://doi.org/10.1016/j.mimet.2015.11.018.

    Article  PubMed  Google Scholar 

  25. 25.

    Versage JL, Severin DD, Chu MC, Petersen JM. Development of a multitarget real-time TaqMan PCR assay for enhanced detection of Francisella tularensis in complex specimens. J Clin Microbiol. 2003;41(12):5492–9. https://doi.org/10.1128/JCM.41.12.5492-5499.2003.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Francy D, Bushon R, Brady A, Bertke E, Kephart C, Likirdopulos C, et al. Comparison of traditional and molecular analytical methods for detecting biological agents in raw and drinking water following ultrafiltration. J Appl Microbiol. 2009;107(5):1479–91. https://doi.org/10.1111/j.1365-2672.2009.04329.x.

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    Gyuranecz M, Rigó K, Dán Á, Földvári G, Makrai L, Dénes B, et al. Investigation of the ecology of Francisella tularensis during an inter-epizootic period. Vector Borne Zoonotic Dis. 2011;11(8):1031–5. https://doi.org/10.1089/vbz.2010.0091.

    Article  PubMed  Google Scholar 

  28. 28.

    Reintjes R, Dedushaj I, Gjini A, Jorgensen TR, Cotter B, Lieftucht A, et al. Tularemia outbreak investigation in Kosovo: case control and environmental studies. Emerg Infect Dis. 2002;8(1):69–73. https://doi.org/10.3201/eid0801.010131.

    Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Davut O, Irfan S, Ali Nihat A, Aynur K, Ertugrul G, Erhan S, et al. Comparison of the 2000 and 2005 outbreaks of tularemia in the Duzce region of Turkey. Jpn J Infect Dis. 2007;60(1):51–2.

    Google Scholar 

  30. 30.

    Saban G, Muzaffer E, Gamze V, Cem U, Müşerref T-O, Nermin S, et al. Tularemia re-emerging in European part of Turkey after 60 years. Jpn J Infect Dis. 2006;59(6):391–3.

    Google Scholar 

  31. 31.

    Leblebicioglu H, Esen S, Turan D, Tanyeri Y, Karadenizli A, Ziyagil F, et al. Outbreak of tularemia: a case–control study and environmental investigation in Turkey. Int J Infect Dis. 2008;12(3):265–9. https://doi.org/10.1016/j.ijid.2007.06.013.

    Article  PubMed  Google Scholar 

  32. 32.

    Yazgı H, Uyanık M, Ertek M, Kılıç S, Kirecci E, Ozden K, et al. Tularemia seroprevalence in the risky population living in both rural and urban areas of Erzurum. Mikrobiyol Bul. 2011;45(1):67–74.

    PubMed  Google Scholar 

  33. 33.

    Caspar Y, Maurin M. Francisella tularensis susceptibility to antibiotics: a comprehensive review of the data obtained in vitro and in animal models. Front Cell Infect Microbiol. 2017;7:122.

    Article  Google Scholar 

Download references

Acknowledgements

The authors of this study would like to express their sincere terms of gratitude to the employees of the department for health affairs of the Tabriz University of Medical Sciences, especially Mr. Saber Alizadeh, and all the health personnel in the Kaleybar County and Youzband village health house for their kind cooperation in sampling and follow up of the patents.

Funding

This project was supported by Pasteur Institute of Iran and Center for Communicable Diseases Control in the Ministry of Health (Grant No. 810).

Author information

Affiliations

Authors

Contributions

EM, MMG and SK helped in the conception and design of the study. EM, MR, AG, SE and AM contributed to data collection. EM, MR, HAC and SE helped in the first draft writing. EM, AJ and MM did the final draft. All authors contributed to the final approval of the version to be submitted. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Ehsan Mostafavi.

Ethics declarations

Ethics approval and consent to participate

The Medical Ethics Committee of Pasteur Institute of Iran approved the study (IR.PII.REC.1395.9). All protocols of this study were approved by Medical Ethics Committee of Pasteur Institute of Iran. The informed consent and signature of the informed consent were completed by adult participants and parents or legal guardians of minors. Consent from participants were obtained for publishing of all forms of personally identifiable data including biomedical, clinical, identifying information/images and biometric data. All experiments were performed in accordance with relevant guidelines and regulations. Also, all animals’ experiments were carried out in compliance with the ARRIVE guidelines. All stages of this study have been under the constant supervision of the Medical Ethics Committee of Pasteur Institute of Iran.

Consent for publication

Consent from all participants were obtained for publishing of all forms of personally identifiable data including biomedical, clinical, identifying information/images and biometric data.

Competing interests

No conflict of interest is declared.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Esmaeili, S., Rohani, M., Ghasemi, A. et al. Francisella tularensis human infections in a village of northwest Iran. BMC Infect Dis 21, 310 (2021). https://doi.org/10.1186/s12879-021-06004-y

Download citation

Keywords

  • Francisella tularensis
  • Water
  • Tularemia
  • Rodent
  • Chlorination